Annual report pursuant to Section 13 and 15(d)

Balance Sheets

v3.23.1
Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash $ 13,468,026 $ 27,204,269
Acquired patents, net 9,003 12,615
Total assets 13,477,029 27,216,884
Current liabilities    
Accounts payable & accrued interest 220,845 220,845
Unreimbursed expenses 42,060 164,327
Total current liabilities 262,905 385,172
Total liabilities 262,905 385,172
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,848,165 and 13,147,829 shares issued and outstanding as of December 31, 2022 and 2021, respectively 12,848 13,148
Additional paid-in capital 54,674,042 60,466,093
Accumulated deficit (41,472,766) (33,647,529)
Total stockholders’ equity 13,214,124 26,831,712
Total liabilities and stockholders’ equity $ 13,477,029 $ 27,216,884